CDC’s Investments to Combat Antibiotic Resistance Threats: New York: Fiscal Year 2018

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  $6,481,046 Funding for AR Activities Fiscal Year 2018
  
  1 local CDC AR expert and 2 CDC fellow
  
  Regional Lab for the AR Lab Network (Northeast)
  
  One of 10 sites for the Emerging Infections Program
  
  See CDC’s AR investments by state at www.cdc.gov/ARinvestments.
  
  Publication date from document properties.
  
  https://wwwn.cdc.gov/ARInvestments/PDFDocs/New-York-CDC-AR-Investments.pdf
  
  
• Subjects:
  Antimicrobial Stewardship Carbapenem-Resistant Enterobacteriaceae Communicable Diseases, Emerging Cross Infection/prevention & Control Drug Resistance, Microbial Financing, Government Food Safety Gonorrhea/prevention & Control Local Government Public Health State Government

  More +
• Series:
  Antibiotic Resistance (AR) Solutions in Action
• Document Type:
  Text
• Genre:
  Fact Sheet
• Place as Subject:
  New York
• Pages in Document:
  2 numbered pages
• Federal Fiscal Year:
  2018
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:5f5f1eed91f1fca10553831c1e814d30cb5612721583f973ea6468cc7722e7e298f21dabcb0fa629e74bf0273546990769085c23cb74a4376b122bce59c942c7
• Download URL:
  https://stacks.cdc.gov/view/cdc/62163/cdc_62163_DS1.pdf
• File Type:
  [PDF - 805.46 KB ]